中医学报2017，Vol.32Issue(7)：1247-1250,4.DOI:10.16368/j.issn.1674-8999.2017.07.328
胸痹方治疗冠状动脉粥样硬化性心脏病心力衰竭临床研究
Clinical Study of Xiongbi Prescription in Treatment Heart Failure with Coronary Atherosclerotic Heart Disease
摘要
Abstract
Objective:To observe the clinical curative effect of Xiongbi Prescription in treatment of heart failure with Coronary atherosclerotic heart disease (CHD) in patients.Methods:Sixty patients of heart failure with coronary atherosclerotic heart disease were randomly divided into two groups.The control group (n =30) received conventional western medicine.The treatment group (n =30) received treatment of Xiongbi Prescription in addition to that of the conventional western medicine.The changes of TCM syndrome scores,electrocardiogram,cardiac function and 6-minute walking distances of both groups were analyzed before and after treatment,and the clinical curative effects were evaluated.Results:The TCM syndrome scores,electrocardiogram,cardiac function and 6-minute walking distances of the two groups were improved after treatment.Compared with those of the control group,the differences were statistically significant (P ＜ 0.05).Conclusion:Xiongbi Prescription can obviously improve the heart function of patients with heart failure with coronary atherosclerotic heart disease and improve the quality of life The clinical efficacy is remarkable.关键词
冠状动脉粥样硬化性心脏病/心力衰竭/胸痹方/气滞痰瘀证/中医药治疗/中西医结合Key words
Coronary atherosclerotic heart disease/heart failure/Xiongbi Prescription/Qi stagnation and Phlegm stasis Syndrome/traditional Chinese medicine/combine traditional Chinese and western medicine分类
医药卫生引用本文复制引用
林志强,王清海..胸痹方治疗冠状动脉粥样硬化性心脏病心力衰竭临床研究[J].中医学报,2017,32(7):1247-1250,4.基金项目
广东省中医药局课题(20164018) （20164018）
